research

August 10, 2022
Christopher Flowers, MD, MS, FASCO; Vicki Keedy, MD; Daniel Mulrooney, MD, MS; and Sumanta (Monty) Pal, MD, FASCO

What to Know About Peer-Reviewed Cancer Information and Its Role in Cancer Research

English
Christopher.Flowers.Vicki.Keedy.Daniel.Mulrooney.Sumanta.Pal

In this post, several experts describe the importance of peer-reviewed cancer information, including what “peer reviewed” means, what to know about levels of scientific evidence in cancer research, and the differences between research done in cell lines, animals, and humans.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 7, 2022
Brielle Gregory Collins, ASCO staff

2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in People 55+ With Luminal A Breast Cancer

English
Brielle.Gregory.Collins

The ASCO Annual Meeting is being held June 3 to 7, and here is some of notable research that will be presented today. Today’s research includes a study evaluating whether radiation therapy can be avoided after surgery for people aged 55 or older with low-grade luminal A breast cancer, as identified through biomarker testing.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 5, 2022
Leslie Fannon Zhang, ASCO staff

2022 ASCO Annual Meeting: Advances in Treating Breast Cancer, Colorectal Cancer, Ewing Sarcoma, and Multiple Myeloma

English
Leslie.Fannon.Zhang

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 4, 2022
Brielle Gregory Collins, ASCO staff

2022 ASCO Annual Meeting: Targeted Therapy for Advanced HR-Positive, HER2-Negative Breast Cancer and Using Liquid Biopsy to Guide Treatment for Stage II Colon Cancer

English
Brielle.Gregory.Collins

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.

Read More >>

Pages

Subscribe to RSS - research